DENVER - A panel of the 10th Circuit U.S. Court of Appeals on Oct. 27 affirmed a $170,000 penalty against the maker of temporomandibular joint (TMJ) implants and its president for knowingly failing to report adverse events to the Food and Drug Administration (TMJ Implants, Inc., et al. v. United States Department of Health and Human Services, No. 08-9539, 10th Cir.). From Mealey's Emerging Drugs & Devices